Latest

• Clinical pharmacology and practical aspects of isavuconazole use

  Clinical Microbiology and Antimicrobial Chemotherapy. 2023; 25(4):379-394

• Changes in the nomenclature of human pathogenic micromycetes

  Clinical Microbiology and Antimicrobial Chemotherapy. 2022; 24(4):292-294

• The current place of echinocandins in the treatment and prophylaxis of invasive fungal infections

  Clinical Microbiology and Antimicrobial Chemotherapy. 2020; 22(3):197-209

• The tablet formulation of posaconazole: clinical pharmacology and the use in patients with hematologic malignancies

  Clinical Microbiology and Antimicrobial Chemotherapy. 2020; 22(2):96-117

• Some issues of the resistance of Candida glabrata to echinocandins

  Clinical Microbiology and Antimicrobial Chemotherapy. 2019; 21(4):324-329

• Review of the ASCO and IDSA clinical practice guidelines on antimicrobial prophylaxis for adult patients with cancer-related immunosupression

  Clinical Microbiology and Antimicrobial Chemotherapy. 2019; 21(1):4-17

• Review of the Guidelines of the Spanish Society of Chemotherapy on antibiotic selection in the treatment of acute invasive infections by Pseudomonas aeruginosa

  Clinical Microbiology and Antimicrobial Chemotherapy. 2018; 20(4):289-309

• Review of updated clinical practice guidelines of the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA) for Clostridium difficile infection in adults and children (2017)

  Clinical Microbiology and Antimicrobial Chemotherapy. 2018; 20(2):76-124

• Susceptibility testing of Candida glabrata clinical strains to echinocandins using SensititreTM YeastOneTM system

  Clinical Microbiology and Antimicrobial Chemotherapy. 2018; 20(1):49-54

• Prognostic rules for invasive candidiasis risk assessment in ICU patients

  Clinical Microbiology and Antimicrobial Chemotherapy. 2017; 19(4):296-302

• Review of the guidelines for the treatment and prevention of invasive candidiasis in newborns and children

  Clinical Microbiology and Antimicrobial Chemotherapy. 2017; 19(2):92-100

• New Drug Formulations of Posaconazole: Brief Clinical Pharmacology Review

  Clinical Microbiology and Antimicrobial Chemotherapy. 2016; 18(4):249-269

• Candida glabrata Resistance to Echinocandins Associated with FKS Genes Mutations: How Urgent is the Problem?

  Clinical Microbiology and Antimicrobial Chemotherapy. 2016; 18(2):130-145

• The New Approach to the Topical Therapy of Onychomycoses

  Clinical Microbiology and Antimicrobial Chemotherapy. 2013; 15(1):23-34

• Anidulafungin: Brief Clinical Pharmacology Review

  Clinical Microbiology and Antimicrobial Chemotherapy. 2012; 14(3):222-234

• Empiric Therapy of Invasive Candidiasis in Intensive Care Units: Current State of Problem

  Clinical Microbiology and Antimicrobial Chemotherapy. 2011; 13(1):4-18

• Empirical, Pre-emptive and Prophylactic Therapy of Invasive Mycoses: Current State of the Problem

  Clinical Microbiology and Antimicrobial Chemotherapy. 2009; 11(4):286-304

• In Vitro Activity of Fluconazole and Voriconazole Against More Than 10000 Yeast Strains: Results of 5-years Prospective ARTEMIS Disk Study in Russia

  Clinical Microbiology and Antimicrobial Chemotherapy. 2008; 10(4):345-354

• Current Options for the Pharmacotherapy of the Invasive Candidiasis in Children

  Clinical Microbiology and Antimicrobial Chemotherapy. 2008; 10(4):292-304

• Review of Clinical Practice Guidelines of Infectious Diseases Society of America on Treatment of Aspergillosis

  Clinical Microbiology and Antimicrobial Chemotherapy. 2008; 10(2):96-142

• Acute Bacterial Rhinosinusitis

  Clinical Microbiology and Antimicrobial Chemotherapy. 2008; 10(1):43-54

• Systemic Antimycotics: Key Aspects and Perspectives

  Clinical Microbiology and Antimicrobial Chemotherapy. 2007; 9(1):73-80

• Ceftibuten: Current Role in the Therapy of Infections

  Clinical Microbiology and Antimicrobial Chemotherapy. 2006; 8(4):368-382

• Amoxicillin/Sulbactam – a New Beta-Lactam/Beta-Lactamase Inhibitor Combination

  Clinical Microbiology and Antimicrobial Chemotherapy. 2006; 8(2):173-185

• Azithromycin: Current Clinical Use

  Clinical Microbiology and Antimicrobial Chemotherapy. 2006; 8(1):18-32

• Spiramycin: the classic and the present

  Клиническая Микробиология и Антимикробная Химиотерапия. 2005; 7(3):301-312

• Epidemiology of Candidiasis Causative Agents and Their Susceptibility to Azoles: Results of ARTEMIS Disk Study in Russia

  Clinical Microbiology and Antimicrobial Chemotherapy. 2005; 7(1):68-76

• Management of Patients with Candidiasis: Overview of New IDSA Guidelines

  Clinical Microbiology and Antimicrobial Chemotherapy. 2004; 6(2):168-185

• New Drugs for the Treatment of Invasive Mycoses

  Clinical Microbiology and Antimicrobial Chemotherapy. 2003; 5(4):342-353

• Moxifloxacin: the Present and the Future in the Sequential Therapy

  Clinical Microbiology and Antimicrobial Chemotherapy. 2003; 5(1):19-31